Italy
· Delayed Price · Currency is EUR Neurocrine Biosciences Statistics
Total Valuation
BIT:1NBIX has a market cap or net worth of EUR 9.57 billion. The enterprise value is 9.06 billion.
| Market Cap | 9.57B |
| Enterprise Value | 9.06B |
Important Dates
The next estimated earnings date is Monday, May 5, 2025.
| Earnings Date | May 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +2.67% |
| Shares Change (QoQ) | -1.34% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 97.75M |
Valuation Ratios
The trailing PE ratio is 29.03.
| PE Ratio | 29.03 |
| Forward PE | n/a |
| PS Ratio | 4.21 |
| PB Ratio | 3.83 |
| P/TBV Ratio | 3.89 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.76, with an EV/FCF ratio of 16.83.
| EV / Earnings | 27.48 |
| EV / Sales | 4.36 |
| EV / EBITDA | 15.76 |
| EV / EBIT | 17.62 |
| EV / FCF | 16.83 |
Financial Position
The company has a current ratio of 3.40, with a Debt / Equity ratio of 0.19.
| Current Ratio | 3.40 |
| Quick Ratio | 3.06 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 0.76 |
| Debt / FCF | 0.89 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 14.16% and return on invested capital (ROIC) is 12.68%.
| Return on Equity (ROE) | 14.16% |
| Return on Assets (ROA) | 10.46% |
| Return on Invested Capital (ROIC) | 12.68% |
| Return on Capital Employed (ROCE) | 18.16% |
| Revenue Per Employee | 1.26M |
| Profits Per Employee | 183,145 |
| Employee Count | 1,800 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 15.99 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.78 |
Income Statement
In the last 12 months, BIT:1NBIX had revenue of EUR 2.27 billion and earned 329.66 million in profits. Earnings per share was 3.18.
| Revenue | 2.27B |
| Gross Profit | 1.54B |
| Operating Income | 563.12M |
| Pretax Income | 469.43M |
| Net Income | 329.66M |
| EBITDA | 589.30M |
| EBIT | 563.12M |
| Earnings Per Share (EPS) | 3.18 |
Balance Sheet
The company has 1.04 billion in cash and 478.80 million in debt, giving a net cash position of 560.61 million.
| Cash & Cash Equivalents | 1.04B |
| Total Debt | 478.80M |
| Net Cash | 560.61M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 2.50B |
| Book Value Per Share | 25.16 |
| Working Capital | 1.18B |
Cash Flow
In the last 12 months, operating cash flow was 575.10 million and capital expenditures -36.90 million, giving a free cash flow of 538.20 million.
| Operating Cash Flow | 575.10M |
| Capital Expenditures | -36.90M |
| Free Cash Flow | 538.20M |
| FCF Per Share | n/a |
Margins
Gross margin is 67.52%, with operating and profit margins of 24.75% and 14.49%.
| Gross Margin | 67.52% |
| Operating Margin | 24.75% |
| Pretax Margin | 20.63% |
| Profit Margin | 14.49% |
| EBITDA Margin | 25.90% |
| EBIT Margin | 24.75% |
| FCF Margin | 23.66% |
Dividends & Yields
BIT:1NBIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.67% |
| Shareholder Yield | -2.67% |
| Earnings Yield | 3.44% |
| FCF Yield | 5.62% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BIT:1NBIX has an Altman Z-Score of 8.68.
| Altman Z-Score | 8.68 |
| Piotroski F-Score | n/a |